Search

Jeffrey P. Mornhinweg

Examiner (ID: 16856, Phone: (571)270-5272 , Office: P/1793 )

Most Active Art Unit
1793
Art Unit(s)
1793, 1789
Total Applications
631
Issued Applications
204
Pending Applications
106
Abandoned Applications
354

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19164780 [patent_doc_number] => 11980662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-14 [patent_title] => Influenza virus vectors and uses therefor [patent_app_type] => utility [patent_app_number] => 17/675297 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 79 [patent_no_of_words] => 38974 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675297 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/675297
Influenza virus vectors and uses therefor Feb 17, 2022 Issued
Array ( [id] => 19061223 [patent_doc_number] => 11940449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-26 [patent_title] => Specific antigen sequences for COVID-19 and methods of use [patent_app_type] => utility [patent_app_number] => 17/669979 [patent_app_country] => US [patent_app_date] => 2022-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10771 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669979 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/669979
Specific antigen sequences for COVID-19 and methods of use Feb 10, 2022 Issued
Array ( [id] => 19135778 [patent_doc_number] => 11970709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Adenoviral vector [patent_app_type] => utility [patent_app_number] => 17/587376 [patent_app_country] => US [patent_app_date] => 2022-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 16152 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587376 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/587376
Adenoviral vector Jan 27, 2022 Issued
Array ( [id] => 18732565 [patent_doc_number] => 11801285 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-31 [patent_title] => Methods and compositions for treating coronavirus infections [patent_app_type] => utility [patent_app_number] => 17/585022 [patent_app_country] => US [patent_app_date] => 2022-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 19004 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585022 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/585022
Methods and compositions for treating coronavirus infections Jan 25, 2022 Issued
Array ( [id] => 18955618 [patent_doc_number] => 20240043945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => CATALYTIC AMPLIFICATION BY TRANSITION-STATE MOLECULAR SWITCHES FOR DIRECT AND SENSITIVE DETECTION OF SARS-COV-2 [patent_app_type] => utility [patent_app_number] => 18/275540 [patent_app_country] => US [patent_app_date] => 2022-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12640 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275540 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/275540
CATALYTIC AMPLIFICATION BY TRANSITION-STATE MOLECULAR SWITCHES FOR DIRECT AND SENSITIVE DETECTION OF SARS-COV-2 Jan 23, 2022 Pending
Array ( [id] => 17805914 [patent_doc_number] => 20220257749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => INFLUENZA VIRUS HEMAGGLUTININ PROTEINS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/583088 [patent_app_country] => US [patent_app_date] => 2022-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 125644 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583088 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/583088
Influenza virus hemagglutinin proteins and uses thereof Jan 23, 2022 Issued
Array ( [id] => 18955618 [patent_doc_number] => 20240043945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => CATALYTIC AMPLIFICATION BY TRANSITION-STATE MOLECULAR SWITCHES FOR DIRECT AND SENSITIVE DETECTION OF SARS-COV-2 [patent_app_type] => utility [patent_app_number] => 18/275540 [patent_app_country] => US [patent_app_date] => 2022-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12640 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275540 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/275540
CATALYTIC AMPLIFICATION BY TRANSITION-STATE MOLECULAR SWITCHES FOR DIRECT AND SENSITIVE DETECTION OF SARS-COV-2 Jan 23, 2022 Pending
Array ( [id] => 17775047 [patent_doc_number] => 20220241396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => MUTATIONS THAT CONFER GENETIC STABILITY TO GENES IN INFLUENZA VIRUSES [patent_app_type] => utility [patent_app_number] => 17/578939 [patent_app_country] => US [patent_app_date] => 2022-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38341 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 460 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578939 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/578939
MUTATIONS THAT CONFER GENETIC STABILITY TO GENES IN INFLUENZA VIRUSES Jan 18, 2022 Abandoned
Array ( [id] => 17960404 [patent_doc_number] => 20220340984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM [patent_app_type] => utility [patent_app_number] => 17/576974 [patent_app_country] => US [patent_app_date] => 2022-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576974 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/576974
LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM Jan 15, 2022 Pending
Array ( [id] => 17960404 [patent_doc_number] => 20220340984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM [patent_app_type] => utility [patent_app_number] => 17/576974 [patent_app_country] => US [patent_app_date] => 2022-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576974 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/576974
LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM Jan 15, 2022 Pending
Array ( [id] => 17760070 [patent_doc_number] => 20220233682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => VACCINE COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS [patent_app_type] => utility [patent_app_number] => 17/573806 [patent_app_country] => US [patent_app_date] => 2022-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24280 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573806 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/573806
VACCINE COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS Jan 11, 2022 Abandoned
Array ( [id] => 19374157 [patent_doc_number] => 12065707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-20 [patent_title] => Compositions, kits and methods for detection of viral sequences [patent_app_type] => utility [patent_app_number] => 17/567411 [patent_app_country] => US [patent_app_date] => 2022-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 36648 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17567411 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/567411
Compositions, kits and methods for detection of viral sequences Jan 2, 2022 Issued
Array ( [id] => 18988178 [patent_doc_number] => 20240060147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => PATHOGEN DETECTION IN LIQUID MATRIX [patent_app_type] => utility [patent_app_number] => 18/260181 [patent_app_country] => US [patent_app_date] => 2021-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15671 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260181 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/260181
PATHOGEN DETECTION IN LIQUID MATRIX Dec 29, 2021 Pending
Array ( [id] => 18988178 [patent_doc_number] => 20240060147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => PATHOGEN DETECTION IN LIQUID MATRIX [patent_app_type] => utility [patent_app_number] => 18/260181 [patent_app_country] => US [patent_app_date] => 2021-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15671 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260181 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/260181
PATHOGEN DETECTION IN LIQUID MATRIX Dec 29, 2021 Pending
Array ( [id] => 18932531 [patent_doc_number] => 11884939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Vaccinia virus mutants useful for cancer immunotherapy [patent_app_type] => utility [patent_app_number] => 17/565332 [patent_app_country] => US [patent_app_date] => 2021-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 99 [patent_no_of_words] => 31190 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565332 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/565332
Vaccinia virus mutants useful for cancer immunotherapy Dec 28, 2021 Issued
Array ( [id] => 17532424 [patent_doc_number] => 20220111033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => Methods and Compositions for Heterologous repRNA Immunizations [patent_app_type] => utility [patent_app_number] => 17/645556 [patent_app_country] => US [patent_app_date] => 2021-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15686 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17645556 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/645556
Methods and compositions for heterologous repRNA immunizations Dec 21, 2021 Issued
Array ( [id] => 18590255 [patent_doc_number] => 11739138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-29 [patent_title] => Compositions and methods for identifying and sorting antigen-specific B cells [patent_app_type] => utility [patent_app_number] => 17/557180 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 20 [patent_no_of_words] => 10786 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557180 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/557180
Compositions and methods for identifying and sorting antigen-specific B cells Dec 20, 2021 Issued
Array ( [id] => 18085778 [patent_doc_number] => 11535900 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-12-27 [patent_title] => Methods and systems for analysis of samples containing particles used for gene delivery [patent_app_type] => utility [patent_app_number] => 17/554830 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 17585 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554830 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/554830
Methods and systems for analysis of samples containing particles used for gene delivery Dec 16, 2021 Issued
Array ( [id] => 18986468 [patent_doc_number] => 20240058437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => IMMUNOGENIC PEPTIDE [patent_app_type] => utility [patent_app_number] => 18/267241 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17797 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267241 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/267241
IMMUNOGENIC PEPTIDE Dec 16, 2021 Pending
Array ( [id] => 19112780 [patent_doc_number] => 20240124530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => RNA CONSTRUCT [patent_app_type] => utility [patent_app_number] => 18/257698 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40525 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257698 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/257698
RNA CONSTRUCT Dec 16, 2021 Pending
Menu